Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC3711 Npd7155

Novel competitive MTH1 inhibitor

924764-38-5
DCC3712 Npd8617

Novel tubulin inhibitor

313481-28-6
DCC3713 Npd9055

Novel heterotrimeric G-protein Gi modulator, inhibiting GDP/GTP exchange on a Gαi subunit induced by a G-protein-coupled receptor agonist, but not on another G-protein from the Gαs family, regulating Gβγ-dependent cellular processes, most likely by causin

327102-63-6
DCC3714 Nplc0393

Novel inhibitor of TGF-β1 signaling pathway, inhibiting the upregulation of MAT2A mechanistically, dose-dependently activating PP2Cα and efficiently alleviating liver fibrosis

862286-45-1
DCC3715 Npr-c Activator 1

Novel potent activator of the natriuretic peptide receptor C (NPR-C) with EC 50 ~1 μM

DCC3716 Nps-89636

Calcilytic negative allosteric modulator of calcium-sensing receptor (CaR)

1588949-48-7
DCC3717 Nqo1 Substrate 1

Novel substrate for NAD(P)H: quinone oxidoreductase 1 (NQO1), acting as an effective intracellular ROS generator for the treatment of drug-resistant non-small-cell lung cancer

2304503-05-5
DCC3718 Nr2b-in-1

Novel NMDA/NR2B Antagonist

913574-42-2
DCC3719 Nrf2/ho-1 Activator Ll202

Novel activator of the Nrf2/HO-1 pathway, upregulating heme oxygenase-1 (HO-1) via promoting nuclear translocation of nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) to regulate LPS‐induced oxidative stress in macrophages

DCC3720 Nrf2-activator Featured

Nrf2-Activator is a potent Nrf-2 activator.

1554271-18-9
DCC3721 Ns-0011

Novel inhibitor of CDK5 translocation, increasing CDK5 accumulation in the nucleus, suppressing both cancer cell proliferation and xenograft tumorigenesis.

1076234-33-7
DCC3722 Ns-2710

Potent, non-selective partial agonist at GABAA receptors with little efficacy at the alpha1 subtype and more at alpha2 and alpha3

184220-36-8
DCC3723 ns3/4a-in-12

Novel Inhibitor with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes

DCC3724 ns3-in-5

Novel allosteric inhibitor of HCV NS3 protein function

1434713-38-8
DCC3725 Ns4591

Novel molulator of SK-IK channels [small- and intermediate-conductance Ca2(+) -activated K(+) channels]

273930-52-2
DCC3726 Ns-6740

Novel potent α7 nAChR partial agonist

753499-14-8
DCC3727 Ns-6784 Hydrochloride

Novel α7 nAChR agonist at human and rat receptors

677723-97-6
DCC3728 Nsc10010

Novel potent growth inhibitor for gammaherpesvirus-associated B-lymphomas through activation of both the NF-κB and c-Myc-mediated signaling pathways

6286-09-5
DCC3729 Nsc1008

Novel Inhibitor of the Ras Converting Enzyme 1 (Rce1) Protease, Disrupting Ras Membrane Localization in Human Cells

5335-95-5
DCC3730 Nsc-100874

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

1135059-20-9
DCC3731 Nsc1011

Ras converting enzyme 1 (Rce1) inhibitor

5335-97-7
DCC3732 Nsc103054

Novel inhibitor of ABCG2 transporter function

19590-55-7
Page 1391 / Total 1558 FirstPrevNextLastGoto